COLONYVAQ™, a Quantum-Classical Guided Personalized Neoantigen Vaccine for MSS Stage III Colorectal Cancer

NCT07328087 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer Metastatic
Colorectal Cancer Stage III
Colorectal Cancer Stage IV

Interventions

BIOLOGICAL: Experimental: COLONYVAQ-CRC + mFOLFOX6 or CAPOX + Nivolumab

Sponsor

Biogenea Pharmaceuticals Ltd.

Collaborators

[object Object]